NATIONAL HEALTH INVESTORS (NYSE: NHI) director adds 890 shares in open-market purchase

Rhea-AI Filing Summary

NATIONAL HEALTH INVESTORS INC director Robert A. McCabe Jr. reported an open-market purchase of 890 shares of common stock at $71.6485 per share. Following this transaction, he directly owns 44,158.96 shares. This filing reflects a modest increase in his personal investment in the company.

Insider Trade Summary

Net Buyer: 890 shares

Net Buy 1 txn

Insider MCCABE ROBERT A JR

Role Director

Bought 890 shs ($64K)

Type	Security	Shares	Price	Value
Purchase	Shares Of Common Stock	890	$71.6485	$64K

Holdings After Transaction: Shares Of Common Stock — 44,158.96 shares (Direct)

Key Figures

Shares purchased: 890 shares Purchase price: $71.6485 per share Shares owned after: 44,158.96 shares

3 metrics

Shares purchased 890 shares Open-market purchase of common stock

Purchase price $71.6485 per share Price paid in the reported transaction

Shares owned after 44,158.96 shares Direct holdings following the transaction

Key Terms

open-market purchase, Shares Of Common Stock, Purchase in open market or private transaction

3 terms

open-market purchase financial

"transaction_action: "open-market purchase" for 890 shares of common stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Shares Of Common Stock financial

"security_title: "Shares Of Common Stock" in the non-derivative transaction"

Purchase in open market or private transaction financial

"transaction_code_description: "Purchase in open market or private transaction""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/15/2026 - 05:21 PM Accepted by SEC EDGAR 06/15/2026 - 05:21 PM Learn about SEC filing dates

FAQ

What insider transaction did NHI director Robert A. McCabe Jr. report?

Robert A. McCabe Jr. reported buying 890 shares of NATIONAL HEALTH INVESTORS INC common stock. The shares were acquired in an open-market purchase at a price of $71.6485 per share, as disclosed in the Form 4 insider filing.

At what price did the NHI director buy shares in this Form 4 filing?

The director bought NATIONAL HEALTH INVESTORS INC shares at $71.6485 per share. This price reflects the cost per share for the 890-share open-market purchase reported in the Form 4 insider transaction data.

How many NHI shares does Robert A. McCabe Jr. own after this transaction?

After the reported purchase, Robert A. McCabe Jr. directly owns 44,158.96 NATIONAL HEALTH INVESTORS INC shares. This total represents his direct holdings following the 890-share open-market acquisition disclosed in the Form 4 filing.

Was the NHI insider transaction a purchase or sale of shares?

The transaction was a purchase of shares. The Form 4 classifies it as an open-market purchase, with a transaction code P and a transaction_direction field indicating a buy of 890 NATIONAL HEALTH INVESTORS INC common shares.

Does the NHI Form 4 filing show any derivative security transactions?

No derivative security transactions appear in this Form 4 data. The filing shows only one non-derivative transaction: an open-market purchase of 890 shares of NATIONAL HEALTH INVESTORS INC common stock by director Robert A. McCabe Jr.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCCABE ROBERT A JR

(Last) (First) (Middle)

21 PLATFORM SOUTH

SUITE 2300

(Street)

NASHVILLE TENNESSEE 37203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Shares Of Common Stock	06/15/2026		P		890	A	$71.6485	44,158.96	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/Robert A. McCabe, Jr.	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)